Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 2/20 | 0.65 |
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.63 |
| ▸ | CNR1 | P21554 | 4/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.57 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17431042 | 0.92 | EPHX2 (0.58) | EPHX2SLC6A5CNR1KDM4ELPAR1 | |
| SCHEMBL17431039 | 0.92 | EPHX2 (0.58) | EPHX2SLC6A5CNR1KDM4ELPAR1 | |
| SCHEMBL20305887 | 0.91 | CASP2 (0.67) | EPHX2SLC6A5 | |
| SCHEMBL20305888 | 0.91 | CASP2 (0.67) | EPHX2SLC6A5 | |
| SCHEMBL889318 | 0.91 | CASP2 (0.67) | EPHX2SLC6A5 | |
| SCHEMBL25285302 | 0.90 | SLC6A5 (0.71) | EPHX2SLC6A5CNR1KDM4ELPAR1 | |
| SCHEMBL24412966 | 0.89 | CASP2 (0.63) | EPHX2SLC6A5 | |
| SCHEMBL25247574 | 0.89 | EPHX2 (0.63) | EPHX2SLC6A5CNR1KDM4E | |
| SCHEMBL24412947 | 0.88 | CASP2 (0.67) | EPHX2SLC6A5 | |
| SCHEMBL12792095 | 0.88 | CASP2 (0.67) | EPHX2SLC6A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10006128-B2 | Quaternary and cationic ammonium surfactants as corrosion inhibitors | ECOLAB USA INC. (US) | 2018-06-26 | — | — | US | disclosed |
| US-9505707-B2 | Composition and method for reducing hydrate agglomeration | NALCO COMPANY (US) | 2016-11-29 | — | — | US | disclosed |
| US-9505707-B2 | Composition and method for reducing hydrate agglomeration | NALCO COMPANY (US) | 2016-11-29 | — | — | US | disclosed |
| US-20120161070-A1 | COMPOSITION AND METHOD FOR REDUCING HYDRATE AGGLOMERATION | HARBISON-FISCHER, INC. | 2012-06-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120161070-A1 | COMPOSITION AND METHOD FOR REDUCING HYDRATE AGGLOMERATION | AQP1, AQP3, HRH3 | EPHX2 1954/4885SLC6A5 423/4885CNR1 78/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.